State of Tennessee, Department of Treasury’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.3M Sell
981,696
-39,390
-4% -$1.31M 0.1% 176
2026
Q1
$30.8M Buy
1,021,086
+127,896
+14% +$4.11M 0.1% 187
2025
Q4
$30.4M Buy
+893,190
New +$22M 0.1% 188
2024
Q2
Sell
-129,358
Closed -$1.83M 1750
2024
Q1
$1.83M Hold
129,358
0.01% 893
2023
Q4
$1.35M Buy
+129,358
New +$1.21M 0.01% 1037
2022
Q3
Sell
-334,439
Closed -$2.52M 1689
2022
Q2
$2.52M Buy
+334,439
New +$2.91M 0.01% 706
2016
Q4
Sell
-320,112
Closed -$14.7M 1534
2016
Q3
$14.7M Sell
320,112
-185,534
-37% -$9.68M 0.07% 281
2016
Q2
$25.4M Buy
+505,646
New +$26.9M 0.13% 185
2016
Q1
Sell
-460,093
Closed -$30.2M 1441
2015
Q4
$30.2M Hold
460,093
0.18% 146
2015
Q3
$25.9M Sell
460,093
-118,313
-20% -$7.67M 0.16% 160
2015
Q2
$34.2M Buy
578,406
+424,000
+275% +$26.2M 0.19% 138
2015
Q1
$9.62M Sell
154,406
-56,694
-27% -$3.3M 0.05% 380
2014
Q4
$12.1M Buy
+211,100
New +$11.8M 0.06% 307

Other funds holding TEVA

State of Tennessee, Department of Treasury's TEVA Position: Q2 2026 in Review

State of Tennessee, Department of Treasury reduced its Teva Pharmaceuticals (TEVA) stake by 3.9% in Q2 2026, selling an estimated $1.31M and leaving 981,696 shares worth $33.3M. The position accounts for 0.1% of the portfolio, ranked #176.

State of Tennessee, Department of Treasury first reported a position in TEVA in Q4 2014 and has held it in 13 quarters since. The position peaked at $34.2M in Q2 2015. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • State of Tennessee, Department of Treasury held 981,696 shares of Teva Pharmaceuticals worth $33.3M as of Q2 2026.
  • State of Tennessee, Department of Treasury sold 39,390 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.31M.
  • Teva Pharmaceuticals made up 0.1% of State of Tennessee, Department of Treasury's portfolio in Q2 2026, its #176 holding.
  • State of Tennessee, Department of Treasury first reported a position in Teva Pharmaceuticals in Q4 2014 and has held it in 13 quarters since.
  • State of Tennessee, Department of Treasury's Teva Pharmaceuticals position peaked at $34.2M in Q2 2015.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2026, filed 14 Aug 2026.